Particle Size Analysis Market worth $492 million by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Particle Size Analysis Market by Technology (Laser Diffraction, DLS, Imaging, Coulter Principle, Sieving, Nanoparticle Tracking), Dispersion (Wet, Dry, Spray), Enduser (Pharma-biotech, Cosmeceutical, Chemicals, Food, Academia) - Global Forecasts to 2026", published by MarketsandMarkets™, the market size is projected to reach USD 492 million by 2026 from USD 371 million in 2021, growing at a CAGR of 5.8%.

Browse in-depth TOC on "Particle Size Analysis Market"
116 – Tables
37 – Figures
209 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833  

Increasing research activities in the field of nanotechnology, increasing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries fueling the growth of the market. Moreover, increasing government support for nanotechnology research and rapidly growing pharmaceutical industry in emerging countries, are some of the other major factors driving the growth of this market.

The laser diffraction segment accounted for the largest share of the particle size analysis market, by technology, in 2020

Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, sieve analysis and other technologies. The laser diffraction segment accounted for the largest share of this market in 2020, driven by growing initiatives to create awareness about laser diffraction, increasing trainings conducted by companies, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=74084833  

Dynamic imaging to dominate the imaging market during the forecast period

Based on type, the imaging market is segmented into two major types—dynamic imaging, and static imaging. Factors such as high-quality/resolution images, better image recognition, user friendliness, individual sample measurement, and high speed analysis are driving the growth of the dynamic imaging segment.

Nanoparticle Tracking Analysis (NTA) to register the highest growth over the forecast period among particle size analysis technologies

The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth over the forecast among the particle size analysis technologies market over the forecast period. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology. In addition, NTA is mainly used in biopharma and biotech applications and with increasing R&D activities in the biopharmaceutical industry, this market segment is expected to show growth during the forecast period.

Speak to Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=74084833

North America to dominate the particle size analysis market during the forecast period

The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of this market in 2020. Presence of a large customer base in the region, relatively low energy prices in the US market as compared to other competitive nations such as the UK and Japan are encouraging the growth of end-use markets (such as mining, minerals, chemicals, petroleum) in the US. Moreover, significant funding for nanotechnology development and strict industrial regulations for particle size analysis for pharmaceutical drugs and food products with respect to drug development and quality control are some of the major factors driving the growth of the life science instrumentation sector in North America.

The major players operating in the global particle size analysis market include Malvern Panalytical Ltd. (UK), HORIBA (Japan), Beckman Coulter, Inc. (US), Anton Paar GmbH (Austria), Aimsizer (China), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), METLLER TOLEDO (US), Micromeritics Instrument Corporation (US), Microtrac Retsch GmbH (Germany), Shimadzu Corporation (Japan), Sympatec GmbH (Germany), and TSI (US), among others.

Pharmaceutical Membrane Filtration Market worth $10.2 billion by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, Nanofiltration), Material (PES, PVDF, PTFE), Application (Final Product (Sterile Filtration), Raw Material, Cell Separation, Water) - Global Forecast to 2025", published by MarketsandMarkets™, the global Pharmaceutical Membrane Filtration Market is expected to grow from USD 5.8 billion in 2020 to USD 10.2 billion by 2025, at a CAGR of 12.0% from 2020 to 2025.

Browse in-depth TOC on "Pharmaceutical Membrane Filtration Market"

326 – Tables
36 – Figures
248 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031

The major factors driving the growth of this market are the increasing adoption of single-use technologies and the growing demand for nanofiltration. Geographical expansion in countries such as Singapore, France, China, and India and the demand for polyamide track-etched membranes in ultrafiltration are likely to provide growth opportunities for players in the market.

Filters segment accounted for the largest share of the pharmaceutical membrane filtration market, by product, in 2019

On the basis of product, the market is segmented into filters, systems, and accessories. Filters formed the largest product segment in this market owing to the high and growing use of different types of membrane filters for various filtration applications in the biopharmaceutical manufacturing industry.

Final product processing segment accounted for the largest share of the pharmaceutical membrane filtration market, by application, in 2019

On the basis of application, the market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing was the largest application segment in the market in 2019. The increasing production of generics, rapid growth in the biopharmaceutical industry, and the increasing adoption of membrane filters in protein purification, sterile filtration, and viral clearance processes are the major factors driving the growth of this application segment.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031

In 2019, North America was the largest regional market for pharmaceutical membrane filtration

The global pharmaceutical membrane filtration market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest market for pharmaceutical membrane filtration, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the US.

The major companies operating in the pharmaceutical membrane filtration market include Merck (Germany), Danaher (US) and Sartorius Stedim Biotech (France).

Browse Related Reports:

Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End Users (Pharma, Biotech, CRO, CMO) - Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/hollow-fiber-filtration-market-267011039.html

Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html

 

 

 

Preimplantation Genetic Testing Market Worth $ 541.8 Million by 2022- Exclusive Market Report by MarketsandMarkets™

 According to a new market research report "Preimplantation Genetic Testing Market by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application (Aneuploidy, Translocations), End User (Fertility Clinics, Research) - Forecast to 2022", published by MarketsandMarkets™, the Global Preimplantation Genetic Testing Market is projected to reach USD 541.8 Million by 2022 from USD 336.4 Million in 2017, at a CAGR of 10.0%.

Browse and in-depth TOC on " Preimplantation Genetic Testing Market "

85 - Tables

42 - Figures

204- Pages

Download PDF Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=605

By application, the aneuploidy segment is expected to be the fastest growing segment in the forecast period 

The aneuploidy segment is expected to grow at the fastest CAGR. Growth of this segment can be attributed to the increasing maternal age, rising incidence of aneuploidy disorders, and strategic initiatives by key players to provide technologically advanced PGS products for aneuploidy screening.

Aneuploidy screening has been reported to increase the chance of successful embryo implantation, decreases miscarriage rate, and reduce the chance of having a child with a chromosome abnormality).

North America dominated the market in 2016 

Geographically, the Preimplantation Genetic Testing Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe. Rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS), and increasing private-public funding to develop and commercialize novel PGS & PGD procedures are the key factors that account for the larger share of the Preimplantation Genetic Testing Market in North America.

Talk To Our Research Analysts: -http://www.marketsandmarkets.com/speaktoanalyst.asp?id=605

As of 2016, the major product manufacturers operating in the global Preimplantation Genetic Testing Market included Illumina, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Rubicon Genomics, Inc. (U.S.), Oxford Gene Technology (U.K.), Yikon Genomics (China), and SciGene Corporation (U.S.), among others. Moreover, as of 2016, major service providers active in the global market included Beijing Genomics Institute (BGI) (China), Good Start Genetics (U.S.), CombiMatrix Corporation (U.S.), Genea Limited (Australia), Invicta Genetics (Poland), and Progenesis (U.S.).

 

Stem Cell Therapy Market worth $401 million by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period.

Browse and in-depth TOC on "Stem Cell Therapy Market"
142 - Tables
45 - Figures
160 - Pages

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

The Market growth is driven mainly by factors such as increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market.

The adipose tissue-derived MSCs segment accounted for the largest share of the cell source segment in the Stem Cell Therapy Market in 2020.

Based on the cell source from which stem cells are obtained, the global market is segmented into four sources. These include adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources (which includes human corneal epithelium stem cells, peripheral arterial-derived stem cells, and induced pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs accounted for the markets largest share due to their increasing utilization in treating inflammatory diseases and wounds & injuries. There are several associated advantages, such as ease of harvesting stem cells by minimally invasive methods, simplicity of the isolation procedure, and better quality & proliferation capacity of adipose tissue-derived stem cells.

The musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment in the Stem Cell Therapy Market in 2020

Based on therapeutic application, the global market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications (which include ocular diseases, fat loss, and peripheral arterial diseases). In 2020, the musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment. The large market share of this segment is attributed to the increasing prevalence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=48

The Asia Pacific region is the fastest-growing region of the Stem Cell Therapy Market in 2020.

The Asia Pacific region is estimated to grow at the highest CAGR in the market during the forecast period. Some of the major factors fueling the growth of the APAC market include regulatory approvals and guidelines for product approvals and the presence of major stem cell players in countries such as South Korea, Japan, India, and Australia.

Key players in the Stem Cell Therapy Market include Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).

Browse Related Reports:

Nerve Repair and Regeneration Market by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html

Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Surgical Robots Market by Product & Service (Instruments & Accessories, Systems, Service), Application (Urological Surgery, Gynecological Surgery, Orthopedic Surgery), End User (Hospitals, Ambulatory Surgery Center) - Analysis and Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 14.4 billion by 2026 from an estimated USD 6.4 billion in 2021, at a CAGR of 17.6%.

Browse in-depth TOC on "Surgical Robots Market"
212 – Tables
35 – Figures
220 – Pages

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

The Growth in this market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and increased funding for medical robot research. The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World.

The COVID-19 pandemic has had a devastating global impact on the world's population and economy. The pandemic has put a significant strain on healthcare systems. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to minimize the possibility of transmission and conserve healthcare resources for COVID-19 patients. The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in the cancellations of elective surgeries worldwide posing a negative impact on the globe.

Instruments and Accessories to account for the largest share in the market

Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services. The instruments & accessories segment commanded the largest share of 53.8% of the market in 2020. This segment is also expected to grow at the highest CAGR of 18.2% during the forecast period. The large share and high growth rate of this segment are mainly driven by the recurrent purchase of instruments & accessories instead of robotic systems, which are a one-time investment.

General surgery to account for the fastest growing application in the market

Based on application, the surgical robots market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment commanded the largest share of 29.5% of the market in 2020. This segment is also projected to register the highest CAGR of 18.2% during the forecast period. Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Asia Pacific to Witness highest growth from 2021 to 2026

North America dominated the surgical robots market, with a share of 63.6% in 2019, while the Asia Pacific region is expected to register the highest CAGR of 18.5% during the forecast period. The large share of the North American market can be attributed to the availability of funding for R&D in surgical robots in this region and the increasing adoption of surgical robots for pediatric surgeries in Canada and general surgery procedures in the US.

Some of the prominent players operating in the Surgical robots market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (Transenterix) (US), Corindus Vascular Robotics (US), Renishaw (UK), Auris Health (US), Medrobotics Corporation (US), Think Surgical (US), Verb Surgical (US), OMNIlife Science (US), CMR  Surgical (US), Preceyes BV (Netherlands), China National Scientific Instruments And Materials Corporation (CSIMC) (China), Microsure (Netherlands), Titan Medical (Canada), avateramedical Gmbh (Germany) and Medicaroid Corporation (Japan).

 

Urinary Catheters Market worth $2.6 billion by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) & Region - Global Forecast To 2025", published by MarketsandMarkets™, the global Urinary Catheters Market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period.

Browse in-depth TOC on "Urinary Catheters Market"

125 – Tables

35 – Figures

165 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629

The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market.

In 2019, the indwelling catheters segment accounted for the largest share of the urinary catheters market

Based on products, the global market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market.

The coated catheter segment is expected to grow at the highest CAGR during the forecast period
By catheter type, the global market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction.

North America was the largest regional market for urinary catheters market in 2019

The market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019. The large share of North America in this market can be attributed to the favorable reimbursement scenario and the rising volume of surgeries in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the growing healthcare spending in emerging Asian countries, rising prevalence of urinary incontinence, and the large target patient population in the region.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132934629

The global urinary catheters market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Other players include Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India).

Browse Related Reports:

Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2026 

https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html

Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025 

https://www.marketsandmarkets.com/Market-Reports/catheters-market-6247803.html